Scientific Library

The research, in full.

The studies, papers and articles that inform how we formulate. Each entry is labelled for what it is: the ingredient it concerns, the type of study and the level of evidence it carries.

30 of 30 entries
2026
Randomised trial Humiome Post LB: L. fermentum CNCM I-2998 + L. delbrueckii subsp. lactis CNCM I-4831

Postbiotic and bowel movement regularity

Reduced weekly bowel movements versus placebo in adults with unusually frequent, soft stools.

2025
Laboratory study Humiome Post LB / Lactobacillus LB-derived postbiotic

Postbiotic and intestinal barrier integrity

Improved barrier recovery and reduced inflammatory signals in human colon organoid models.

2023
Meta-analysis Various probiotic strains and combinations, including L. plantarum 299v

Probiotics and IBS: 82-trial review

Identified specific probiotic strains with improved overall IBS symptom outcomes.

2023
Randomised trial Riboflavin (vitamin B2)

Vitamin B2 and microbial butyrate production

Combined riboflavin study groups showed increased faecal butyrate production.

2022
Laboratory study Enteric-coated DRcaps (HPMC/gellan) with Eudragit S or Cellacefate

Acid-resistant capsules and targeted release

Selected coated capsules resisted stomach-like acidity before releasing at intestinal pH.

2021
Laboratory study Heat-treated Lactobacillus LB postbiotic

Postbiotic and beneficial gut bacteria

Stimulated bifidobacteria growth in laboratory and human faecal fermentation cultures.

2020
Randomised trial Heat-inactivated Bifidobacterium bifidum MIMBb75

Heat-inactivated B. bifidum and IBS symptoms

More participants achieved meaningful IBS symptom relief than with placebo (34% vs 19%).

2020
Systematic review Inulin, including chicory-derived inulin

Inulin and gut microbiome composition

Human studies consistently associated inulin supplementation with increased bifidobacteria.

2020
Meta-analysis Various multi-species probiotics

Multi-strain probiotics and constipation

Multi-species formulations improved stool frequency, consistency and bloating in pooled trials.

2019
Cochrane review Various probiotics, including L. rhamnosus GG

Probiotics and antibiotic-associated diarrhoea in children

Reduced antibiotic-associated diarrhoea in children in pooled clinical trials.

2018
Meta-analysis Dietary fibre interventions, including inulin-type fibres

Dietary fibre and beneficial gut bacteria

Increased gut Bifidobacterium and Lactobacillus populations in pooled human studies.

2018
Meta-analysis Various probiotic species and multi-strain combinations

Probiotics and overall IBS symptom relief

Found beneficial effects on overall IBS symptoms and abdominal pain for selected probiotics.

2015
Scientific evidence assessment Native chicory inulin

Chicory inulin and stool frequency

Review of human studies found that native chicory inulin can increase stool frequency.

2015
Meta-analysis Lacticaseibacillus rhamnosus GG (ATCC 53103)

L. rhamnosus GG and antibiotic-associated diarrhoea

Reduced antibiotic-associated diarrhoea risk in pooled trials, with clearer benefit in children.

2014
Randomised trial Limosilactobacillus reuteri DSM 17938

L. reuteri and bowel movement frequency

Increased weekly bowel movements in adults with functional constipation versus placebo.

2014
Meta-analysis Various probiotics, including B. animalis subsp. lactis strains

Probiotics and more regular bowel movements

In adults with constipation, probiotics improved stool frequency, consistency and transit time.

2013
Meta-analysis Various strains, notably B. animalis subsp. lactis HN019 and DN-173 010

Probiotics and intestinal transit time

Probiotic supplementation shortened intestinal transit time across adult trials.

2012
Randomised trial Lactiplantibacillus plantarum 299v (DSM 9843)

L. plantarum and bloating relief

Reduced abdominal pain and bloating in adults with IBS versus placebo.

2012
Meta-analysis Various probiotic species and combinations

Probiotics and antibiotic-related digestive disruption

Across pooled clinical trials, probiotics lowered the risk of antibiotic-associated diarrhoea.

2012
Laboratory study Riboflavin / flavins; Faecalibacterium prausnitzii

Vitamin B2 and an important gut bacterium

Showed that flavins help F. prausnitzii transfer electrons near oxygen in lab models.

2011
Randomised trial Bifidobacterium bifidum MIMBb75

B. bifidum and overall IBS comfort

Improved overall IBS symptoms, bloating and quality of life versus placebo.

2011
Randomised trial Bifidobacterium animalis subsp. lactis HN019

B. lactis and faster gut transit

Shortened whole-gut transit time and reduced several digestive symptoms.

2011
Randomised trial Lactobacillus acidophilus NCFM + Bifidobacterium lactis Bi-07

Two live cultures and reduced bloating

Reduced abdominal bloating severity in adults with functional bowel disorders.

2010
Scientific evidence assessment Riboflavin (vitamin B2)

Vitamin B2 and normal mucous membranes

Evidence supported riboflavin’s role in maintaining normal mucous membranes and protecting cells from oxidative stress.

2007
Randomised trial Chicory inulin

Chicory inulin and beneficial bifidobacteria

Increased Bifidobacterium levels in healthy adults versus placebo.

2007
Randomised trial Heat-killed Lactobacillus acidophilus LB + fermented culture medium

Heat-inactivated Lactobacillus LB and recovery time

Shortened recovery by about one day in children with established non-rotavirus diarrhoea.

2006
Randomised trial Bifidobacterium longum subsp. infantis 35624 (originally B. infantis 35624)

B. longum subspecies and IBS relief

Improved abdominal discomfort, bloating and bowel symptoms in women with IBS at one tested study level.

2003
Randomised trial Heat-killed Lactobacillus acidophilus LB (Lacteol Fort)

Heat-inactivated Lactobacillus LB and chronic diarrhoea

Reduced stool frequency more than a live-lactobacilli comparator in chronic diarrhoea.

2000
Randomised trial Heat-killed Lactobacillus acidophilus LB (Lacteol Fort)

Heat-inactivated Lactobacillus LB and diarrhoea duration

Shortened acute diarrhoea duration in children receiving oral rehydration therapy.

1996
Small crossover RCT Heat-killed Lactobacillus acidophilus LB (Lacteol Fort)

Lactobacillus LB and overall IBS symptoms

In a small IBS trial, more favourable composite symptom results occurred with Lacteol Fort than placebo.

Know a study we should consider? Get in touch.